Pharmacist Intervention Effect on the Medication Adherence and Blood Pressure Control in Treated Patients

Universidad de Granada1 site in 1 country140 target enrollmentFebruary 2010

ConditionsHypertension

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hypertension
Sponsor: Universidad de Granada
Enrollment: 140
Locations: 1
Primary Endpoint: blood pressure control
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.

Detailed Description

Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.

Registry

clinicaltrials.gov

Start Date

February 2010

End Date

September 2011

Last Updated

9 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Universidad de Granada

Eligibility Criteria

Inclusion Criteria

•Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension.
•Exclusion criteria:
•Patient living with an other Hypertensive patient treated with the same medications
•Pregnant women
•Hypertensive patients with levels of systolic/diastolic blood pressure ≥ 180mmHg/110mmHg
•Patient with secondary hypertension, kidney or liver failure
•Patients already included in a care program for hypertensive patients
•Patients with a new treatment for hypertension (less than 1 month)